Skip to main content

Table 1 Description of eosinophilia (> 500/mm3) in 26 critically ill patients with SARS-CoV-2 pneumonia

From: Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study

  Patients with eosinophilia during ICU stay N = 26
Eosinophil count at ICU admission
 Median eosinophils count (cell/mm3) 5 [0–20]
 Eosinophilia (> 500/mm3) 1 (4)
 Eosinopenia (< 40/mm3) 22 (85)
 No eosinophil 13 (50)
 Normal eosinophil count 3 (11)
Eosinophilia during ICU stay
 Days between ICU admission and eosinophilia 19 [13–28]
 Days between disease onset and eosinophilia 30 [23–38]
 Days between disease onset and pic of eosinophilia 31 [25–42]
 Median eosinophil count (cells/mm3) 900 [678–1350]
 Severe eosinophilia (> 1500/mm3) 6 (23)
 Total duration of eosinophilia (days) 5 [3–12]
 Biphasic eosinophilia 7 (27)
 Administration of β-lactam antibiotics during eosinophilia period 10 (38)
 Temperature > 38.3 °C at least once during eosinophilia period 11 (42)
 Erythematous skin rash during the eosinophilia period 2 (8)
 Treatment with ivermectin for eosinophilia 3 (12)
  1. Continuous variables are reported as median [Interquartile range] and categorical variables are reported as numbers (percentage)